Teva to Present New Data from CONNECT2 Study on its Digihaler System at the American Academy of Allergy, Asthma and Immunology (AAAAI) 2023 Annual Meeting

24.02.2023 - Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that new data on its Digihaler System will be presented at the American Academy of Allergy, Asthma and Immunology (AAAAI) ... Seite 1

Related Keywords

Tanisha Hill ,Digital Health Platform ,Drug Administration ,Digital Health Medical Lead At Teva ,Real World Digihaler System ,Digihaler System ,Senior Medical Director ,Digital Health Medical Lead ,Teva Pharmaceutical Industries ,